US Bancorp DE decreased its stake in Cabot Corporation (NYSE:CBT) by 28.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,444 shares of the specialty chemicals company's stock after selling 6,456 shares during the period. US Bancorp DE's holdings in Cabot were worth $1,367,000 as of its most recent SEC filing. Multiple institutional investors have increased their stakes in Cabot Corporation, with 93.18% of the stock now owned by institutional investors. Natixis Advisors LLC increased its stake by 14.0% during the first quarter, now owning 141,417 shares valued at $11,757,000 after purchasing an additional 17,338 shares. Banque Cantonale Vaudoise bought a new position in shares of Cabot during the first quarter worth about $43,000. Mackenzie Financial Corp grew its position by 18.3%, now owning 7,840 shares valued at $652,000 after buying an additional 1,210 shares. Avantax Advisory Services Inc. grew its position by 5.7%, now owning 22,002 shares valued at $1,829,000 after buying an additional 1,177 shares. Gallacher Capital Management LLC acquired a new stake in Cabot in the first quarter valued at about $646,000. Cabot announced a $0.45 quarterly dividend to be paid on September 11th, representing an annualized yield of 2.3% and a payout ratio of 23.53%. Shares of Cabot traded down $2.16 on Monday, reaching $75.86, with a trading volume of 330,289 shares compared to its average volume of 429,981. The stock has a 50-day moving average of $75.97 and a 200-day moving average of $79.37. Cabot has a current ratio of 2.13, a quick ratio of 1.41, and a debt-to-equity ratio of 0.66. The one-year low is $70.40 and the one-year high is $117.46. The company has a market capitalization of $4.04 billion, a P/E ratio of 9.92, and a beta of 0.87. Cabot reported $1.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.10. The company had a return on equity of 25.68% and a net margin of 11.14%, with revenue of $923.00 million during the quarter, compared to analyst estimates of $957.29 million. Sell-side analysts anticipate Cabot Corporation will post 7.57 EPS for the current fiscal year. UBS Group set a $82.00 price target on shares of Cabot and gave the company a 'neutral' rating in a report on August 5th. Cabot operates through two segments: Reinforcement Materials and Performance Chemicals, offering reinforcing carbons used in tires and industrial products, as well as engineered elastomer composites solutions.

US Bancorp DE Has $1.37 Million Stock Holdings in Cabot Corporation (NYSE:CBT)

US Bancorp DE reduced its stake in Cabot Corporation by 28.2% in the first quarter, selling 6,456 shares and holding 16,444 shares worth $1.367 million as of its latest SEC filing. Multiple institutional investors increased their holdings, with Natixis Advisors LLC, Banque Cantonale Vaudoise, Mackenzie Financial Corp, Avantax Advisory Services Inc., and Gallacher Capital Management LLC all expanding their positions. Cabot announced a $0.45 quarterly dividend with an annualized yield of 2.3% and a payout ratio of 23.53%. The company reported strong earnings of $1.90 EPS, exceeding analyst estimates, and posted a return on equity of 25.68% and net margin of 11.14% on $923 million in revenue. Cabot has a market cap of $4.04 billion, P/E ratio of 9.92, and a beta of 0.87. UBS Group set a $82.00 price target and assigned a 'neutral' rating on August 5th. The stock traded down to $75.86 on Monday, with a 50-day moving average of $75.97 and a 200-day moving average of $79.37.